Market	Type	Industry	Raised	Date
AIM	Placing	Pharmaceuticals & Biotech	£4.0m	Mar 2007

CONTACTS

CEO: Robert Mansfield

ADVISERS

People who read this article also read ...

• MCI acquires Ovation
• Volex secures £40 million
• Funding boost for Albion